For decades, researchers watched Alzheimer’s advance like a slow‑moving fire through a forest—observing the damage but not fully understanding exactly how the flames travel from tree to tree. Now, fresh studies are revealing clear mechanisms by which harmful proteins move across connected brain circuits, offering a coherent picture of how pathology spreads step‑by‑step . The key lies in the relationship between amyloid‑beta plaques and tau tangles—two hallmark abnormalities. New findings confirm that amyloid‑beta first creates a state of neuronal hyper‑activity and hyper‑connectivity, essentially turning brain networks into faster “highways” for tau‑seed movement . Tau itself does not scatter randomly; instead, it propagates primarily along natural, functional communication pathways between neurons, jumping from synapse to synapse like a signal gone awry . Recent large‑scale investigations—combining PET imaging, fMRI connectivity mapping, and genetic analysis—show that each person’s unique brain wiring determines exactly where and how fast tau spreads from early “epicenters” in the temporal lobe outward toward wider cortical areas . Even finer details have emerged: specialized thin protrusions called dendritic nanotubes can act as tiny transport tubes between neighboring cells, helping shuttle toxic forms of amyloid‑beta and tau across short distances . This explains why symptoms progress in predictable stages—memory loss first, then language, judgment, and executive function—mirroring the network‑by‑network advance of tau tangles. The pattern is not just passive accumulation; it is an active, connectivity‑driven process fueled by the very over‑activity triggered by amyloid plaques . Knowing the route changes the whole strategy for treatment: instead of only targeting plaques, therapies could now aim at the transport and transmission itself—blocking tau seeds, quieting hyper‑active networks, or interrupting those nanotube‑like bridges . Several antibody candidates already show promise in slowing tau spread in early trials, and this new understanding gives clearer reasons why they work . Experts emphasize that the puzzle is not fully solved, but the missing link between local protein clumps and widespread disease now has a solid, evidence‑based explanation—one consistent across independent research groups and human‑brain data sets. The discovery also suggests why one‑size‑fits‑all treatments often underperform: because each brain’s network map differs, the exact speed and path of spread vary from person to person—pointing toward personalized approaches based on connectivity “fingerprints”. What began as observing a mysterious, gradual decline is now becoming a traceable biological process—one that may finally be slowed or stopped by targeting not just the fire, but the paths it uses to travel. AI Image Disclaimer: These scientific illustrations are computer‑generated models; they simplify complex structures and are not precise microscopic records.